Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans.

Ranganathan M, Carbuto M, Braley G, Elander J, Perry E, Pittman B, Radhakrishnan R, Sewell RA, D'Souza DC.

Int J Neuropsychopharmacol. 2012 Oct;15(9):1251-64. doi: 10.1017/S1461145711001830. Epub 2012 Jan 16.

PMID:
22243563
2.

Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.

D'Souza DC, Braley G, Blaise R, Vendetti M, Oliver S, Pittman B, Ranganathan M, Bhakta S, Zimolo Z, Cooper T, Perry E.

Psychopharmacology (Berl). 2008 Jul;198(4):587-603. doi: 10.1007/s00213-007-1042-2. Epub 2008 Jan 29.

3.

The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis.

D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, Braley G, Gueorguieva R, Krystal JH.

Neuropsychopharmacology. 2004 Aug;29(8):1558-72.

4.

Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers.

Haney M.

Neuropsychopharmacology. 2007 Jun;32(6):1391-403. Epub 2006 Nov 8.

5.

Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans.

D'Souza DC, Pittman B, Perry E, Simen A.

Psychopharmacology (Berl). 2009 Mar;202(4):569-78. doi: 10.1007/s00213-008-1333-2. Epub 2008 Sep 21.

6.

The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial.

Englund A, Atakan Z, Kralj A, Tunstall N, Murray R, Morrison P.

J Psychopharmacol. 2016 Feb;30(2):140-51. doi: 10.1177/0269881115615104. Epub 2015 Nov 17.

PMID:
26577065
7.

Opioid antagonism enhances marijuana's effects in heavy marijuana smokers.

Cooper ZD, Haney M.

Psychopharmacology (Berl). 2010 Aug;211(2):141-8. doi: 10.1007/s00213-010-1875-y. Epub 2010 May 19.

8.

Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism.

Ranganathan M, Sewell RA, Carbuto M, Elander J, Schnakenberg A, Radhakrishnan R, Pittman B, D'Souza DC.

Psychopharmacology (Berl). 2014 Jun;231(12):2385-93. doi: 10.1007/s00213-013-3402-4. Epub 2014 Jan 15.

PMID:
24424782
9.

Interaction between naltrexone and oral THC in heavy marijuana smokers.

Haney M, Bisaga A, Foltin RW.

Psychopharmacology (Berl). 2003 Feb;166(1):77-85. Epub 2002 Dec 19.

PMID:
12491025
10.

Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.

D'Souza DC, Ranganathan M, Braley G, Gueorguieva R, Zimolo Z, Cooper T, Perry E, Krystal J.

Neuropsychopharmacology. 2008 Sep;33(10):2505-16. doi: 10.1038/sj.npp.1301643. Epub 2008 Jan 9.

11.

Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans.

D'Souza DC, Fridberg DJ, Skosnik PD, Williams A, Roach B, Singh N, Carbuto M, Elander J, Schnakenberg A, Pittman B, Sewell RA, Ranganathan M, Mathalon D.

Neuropsychopharmacology. 2012 Jun;37(7):1632-46. doi: 10.1038/npp.2012.8. Epub 2012 Feb 15.

12.

The opioid antagonist naltrexone reduces the reinforcing effects of Delta 9 tetrahydrocannabinol (THC) in squirrel monkeys.

Justinova Z, Tanda G, Munzar P, Goldberg SR.

Psychopharmacology (Berl). 2004 Apr;173(1-2):186-94. Epub 2003 Dec 11.

PMID:
14668977
13.

Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans.

Wachtel SR, de Wit H.

Drug Alcohol Depend. 2000 Jun 1;59(3):251-60.

PMID:
10812285
14.

Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC.

Lile JA, Kelly TH, Hays LR.

Drug Alcohol Depend. 2012 Nov 1;126(1-2):216-23. doi: 10.1016/j.drugalcdep.2012.05.023. Epub 2012 Jun 13.

15.

Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis.

Bhattacharyya S, Fusar-Poli P, Borgwardt S, Martin-Santos R, Nosarti C, O'Carroll C, Allen P, Seal ML, Fletcher PC, Crippa JA, Giampietro V, Mechelli A, Atakan Z, McGuire P.

Arch Gen Psychiatry. 2009 Apr;66(4):442-51. doi: 10.1001/archgenpsychiatry.2009.17.

PMID:
19349314
16.

Tolerability and effects of oral Delta9-tetrahydrocannabinol in older adolescents with marijuana use disorders.

Gray KM, Hart CL, Christie DK, Upadhyaya HP.

Pharmacol Biochem Behav. 2008 Nov;91(1):67-70. doi: 10.1016/j.pbb.2008.06.011. Epub 2008 Jun 26.

17.

Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.

D'Souza DC, Ahn K, Bhakta S, Elander J, Singh N, Nadim H, Jatlow P, Suckow RF, Pittman B, Ranganathan M.

Biol Psychiatry. 2012 Nov 1;72(9):785-94. doi: 10.1016/j.biopsych.2012.05.009. Epub 2012 Jun 19.

PMID:
22717030
18.

Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers.

Atakan Z, Bhattacharyya S, Allen P, Martín-Santos R, Crippa JA, Borgwardt SJ, Fusar-Poli P, Seal M, Sallis H, Stahl D, Zuardi AW, Rubia K, McGuire P.

Psychol Med. 2013 Jun;43(6):1255-67. doi: 10.1017/S0033291712001924. Epub 2012 Oct 1.

PMID:
23020923
19.

Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol.

Lile JA, Kelly TH, Pinsky DJ, Hays LR.

Psychopharmacology (Berl). 2009 Apr;203(2):241-50. doi: 10.1007/s00213-008-1393-3. Epub 2008 Nov 19.

20.

The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning.

Morrison PD, Zois V, McKeown DA, Lee TD, Holt DW, Powell JF, Kapur S, Murray RM.

Psychol Med. 2009 Oct;39(10):1607-16. doi: 10.1017/S0033291709005522. Epub 2009 Apr 1.

PMID:
19335936

Supplemental Content

Support Center